Locations:
Search
How to tell the difference and why it matters
The case for personalized brain mapping in complex disorders
Phase 3 EXPAND trial suggests potential utility of siponimod
Neural-machine interface makes users feel that an artificial hand is their own
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Novel monoclonal antibody takes aim at alpha-synuclein clusters
New article reviews time-to-treatment data and looks ahead to emerging outcomes and cost studies
Cleveland Clinic’s head of epilepsy surgery reflects on two decades of major progress
Most substantial reversal of amyloid deposition in an animal study to date
Dr. Robert Fox puts a tissue marker study in context
Quantitative imaging of white matter integrity beyond what MRI can do
Advertisement
Advertisement